Mesenchymal stem cell expressing TRAIL as targeted therapy against sensitised tumour
Tapping into the ability of engineered mesenchymal stem cells (MSCs) to mobilise into the tumour has expanded the scope of cancer treatment. Engineered MSCs expressing tumour necrosis factor (TNF)-related apoptosis inducing ligand (MSC-TRAIL) could serve as a platform for an efficient and targeted f...
Saved in:
| Main Authors: | , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
MDPI
2018
|
| 在線閱讀: | http://psasir.upm.edu.my/id/eprint/74939/1/ijms-19-02188.pdf |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|